| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |